Novartis (NYSE: NVS) reported Q3 EPS of $1.74, $0.06 better than the analyst estimate of $1.68. Revenue for the quarter came in at $11.78 billion versus the consensus estimate of $13.08 billion.

OUTLOOK:

Net sales Expected to grow high single digit.

For earnings history and earnings-related data on Novartis (NVS) click here.